ArticleOncotarget2015

A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway.

Azadeh Cheraghchi-Bashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.